ULO
Pre-Launchchlophedianol hydrochloride
NDAORALSYRUP
Lifecycle
Pre-Launch
Clinical Trials
20
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 2mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ULO is an oral syrup formulation of chlophedianol hydrochloride, a small-molecule antitussive agent approved via NDA. The mechanism of action and specific indications are not yet publicly documented. This product is in pre-launch phase, indicating preparation for market entry.
Pre-Launch
Pre-launch stage suggests small, focused commercial team building toward launch execution; significant growth potential if approved with competitive positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous Infection
600 enrolled
HIV InfectionsTuberculosis
A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex
24 enrolled
HIV InfectionsCytopenias
A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy
Mycobacterium Avium-Intracellulare InfectionHIV InfectionsTuberculosis, Mycobacterium Infection
A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
HIV InfectionsCytopenias
The Treatment of Tuberculosis in HIV-Infected Patients
650 enrolled
HIV InfectionsTuberculosis
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.